Clinical trial Recruiting at 1 site Interventional Ages 18 to 70

High Intensity Interval Training for Familial Hypercholesterolemia

Official title: Unraveling the Potential of Physical Activity in the Treatment of Familial Hypercholesterolemia: Impact of Exercise on Cardiorespiratory Fitness, Atherosclerosis Progression, and Underlying Mechanisms

Run by Fundación Pública Andaluza para la Investigación Biomédica Andalucía Oriental · NCT06833944 · Data updated 2026-11-12

The study tests whether high-intensity interval training or moderate-intensity continuous exercise can improve heart and blood vessel health for adults with familial hypercholesterolemia.

Quick facts

Study typeInterventional
Ages18 Years to 70 Years
SexAll
Enrollment75 (estimated)
SponsorFundación Pública Andaluza para la Investigación Biomédica Andalucía Oriental
Academic / other
Locations1 site (Granada, Granada)
StatusRecruiting
StartedFebruary 20, 2025
Main results expectedFebruary 28, 2027
Study endsJuly 31, 2027
Registry record updatedSeptember 22, 2026
Trial IDNCT06833944 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults over 18 with a genetic diagnosis of familial hypercholesterolemia, clinically stable, and with at least one year of follow-up at the Vascular Risk Clinic.

Probably not a fit

Individuals who cannot participate in exercise testing or have contraindications to exercise, or with prior clinical cardiovascular disease, may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study compares two supervised exercise programs—high-intensity interval training (HIIT) and moderate-intensity continuous training (MICT)—to see which more effectively improves cardiorespiratory fitness and early signs of atherosclerosis in adults with familial hypercholesterolemia. Researchers will look at fitness measures and biomarkers to understand the mechanisms behind any changes, including metabolomic signatures. Participants are adults with genetically confirmed FH, stable clinical status, and previous vascular risk clinic follow-up, enrolled at Virgen de las Nieves University Hospital in Granada, Spain. The study is centered on physical activity as an adjunct to cholesterol management and cardiovascular risk reduction.

Why it matters

Potential benefit: If successful, participants may experience improved fitness and healthier blood vessel profiles, potentially lowering cardiovascular risk.

How similar studies have gone: Prior studies in related populations suggest exercise can improve fitness and vascular markers, but this specific comparison of HIIT versus MICT in FH is a novel approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion criteria:

* Individuals with a diagnosis of genetic FH.
* \> 18 years old.
* Minimum follow-up of 1 year in the Vascular Risk Clinic of the Virgen de las Nieves University Hospital (HUVN).
* Clinical and treatment stability.
* Non-pathological angio-TAC of coronary arteries in the 2 years prior to the study (for participants \>45 years old).

Exclusion criteria:

* Inability to read, understand and sign the informed consent.
* Contraindications to exercise.
* History of clinical CVD (ischemic heart disease, stroke, and/or peripheral arterial disease).

Where it's running

  • Virgen de las Nieves University Hospital
    Granada, Granada, Spain
    Recruiting

Study contacts

  • Principal investigator: Jose A Vargas-Hitos, MD, PHD — Virgen de las Nieves University Hospital, Granada, Spain
  • Study coordinator: Jose A Vargas-Hitos, MD, PHD
  • Email: joseantoniovh@hotmail.com
  • Phone: +34625943933

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.